We describe a stereocontrolled synthesis of 3, the
fully glycosylated monomeric unit of the dimeric cytotoxic bacterial
metabolite (−)-lomaiviticin A (2). A novel strategy
involving convergent, site- and stereoselective coupling of the β,γ-unsaturated
ketone 6 and the naphthyl bromide 7 (92%,
15:1 diastereomeric ratio (dr)), followed by radical-based annulation
and silyl ether cleavage, provided the tetracycle 5 (57%
overall), which contains the carbon skeleton of the aglycon of 3. The β-linked 2,4,6-trideoxy-4-aminoglycoside l-pyrrolosamine was installed in 73% yield and with 15:1 β:α
selectivity using a modified Koenigs–Knorr glycosylation. The
diazo substituent was introduced via direct diazo transfer to an electron-rich
benzoindene (4 → 27). The α-linked
2,6-dideoxyglycoside l-oleandrose was introduced by gold-catalyzed
activation of an o-alkynyl glycosylbenzoate (75%,
>20:1 α:β selectivity). A carefully orchestrated endgame
sequence then provided efficient access to 3. Cell viability
studies indicated that monomer 3 is not cytotoxic at
concentrations up to 1 μM, providing conclusive evidence that
the dimeric structure of (−)-lomaiviticin A (2) is required for cytotoxic effects. The preparation of 3 provides a foundation to complete the synthesis of (−)-lomaiviticin
A (2) itself.